Gujarat Themis Biosyn's Stock Sees Decline of -7.13% Amidst Mixed Trend

Gujarat Themis Biosyn, a smallcap pharmaceutical company, has been in the news recently due to its stock performance. On October 22, 2024, the company's stock saw a decline of -7.13%, underperforming the sector by -5.92%. This has led to a 'Hold' call by MarketsMOJO for the stock. The stock has been on a downward trend for the past 8 days, with a consecutive fall of -15.96% in this period. On the same day, the stock touched an intraday low of Rs 282.65, a decrease of -9.47%. The stock has also shown high volatility, with an intraday volatility of 5.41%. In terms of moving averages, the stock is currently higher than the 200 day moving average, but lower than the 5 day, 20 day, 50 day, and 100 day moving averages. This indicates a mixed trend for the stock. In comparison to the Sensex, Gujarat Themis Biosyn's 1 day performance was -4.42%, while the Sensex's performance was -0.62%. Similarly, the company's 1 month performance was -18.47%, while the Sensex's performance was -4.61%. It is important to note that this article is based on factual information and does not include any external data or sources. It is intended to provide a neutral and informative overview of Gujarat Themis Biosyn's recent stock performance. As always, investors are advised to conduct their own research and make informed decisions before investing in any company.